These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 26298810)

  • 1. Constructing an atomic-resolution model of human P2X7 receptor followed by pharmacophore modeling to identify potential inhibitors.
    Ahmadi M; Nowroozi A; Shahlaei M
    J Mol Graph Model; 2015 Sep; 61():243-61. PubMed ID: 26298810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
    Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
    Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
    Jain V; Saravanan P; Arvind A; Mohan CG
    Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.
    Barniol-Xicota M; Kwak SH; Lee SD; Caseley E; Valverde E; Jiang LH; Kim YC; Vázquez S
    Bioorg Med Chem Lett; 2017 Feb; 27(4):759-763. PubMed ID: 28126517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of the 3D structure of 5-HT(1A)R: discovery of novel 5-HT(1A)R agonists via dynamic pharmacophore-based virtual screening.
    Xu L; Zhou S; Yu K; Gao B; Jiang H; Zhen X; Fu W
    J Chem Inf Model; 2013 Dec; 53(12):3202-11. PubMed ID: 24245825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
    Daga PR; Polgar WE; Zaveri NT
    J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
    Faria RX; Oliveira FH; Salles JP; Oliveira AS; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; Louvis AR; Martins DL; Ferreira VF
    Eur J Med Chem; 2018 Jan; 143():1361-1372. PubMed ID: 29133043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
    Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
    J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
    Caseley EA; Muench SP; Fishwick CW; Jiang LH
    Biochem Pharmacol; 2016 Sep; 116():130-9. PubMed ID: 27481062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel inhibitors of tropomyosin-related kinase A through the structure-based virtual screening with homology-modeled protein structure.
    Park H; Chi O; Kim J; Hong S
    J Chem Inf Model; 2011 Nov; 51(11):2986-93. PubMed ID: 22017333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
    Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
    Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors.
    Xue X; Wei JL; Xu LL; Xi MY; Xu XL; Liu F; Guo XK; Wang L; Zhang XJ; Zhang MY; Lu MC; Sun HP; You QD
    J Chem Inf Model; 2013 Oct; 53(10):2715-29. PubMed ID: 24050442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor.
    Fresta CG; Caruso G; Fidilio A; Platania CBM; Musso N; Caraci F; Drago F; Bucolo C
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening based on pharmacophore model followed by docking simulation studies in search of potential inhibitors for p38 map kinase.
    Shahlaei M; Doosti E
    Biomed Pharmacother; 2016 May; 80():352-372. PubMed ID: 27133076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X7 receptor antagonism: Implications in diabetic retinopathy.
    Platania CBM; Giurdanella G; Di Paola L; Leggio GM; Drago F; Salomone S; Bucolo C
    Biochem Pharmacol; 2017 Aug; 138():130-139. PubMed ID: 28479300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket.
    Bin Dayel A; Evans RJ; Schmid R
    Mol Pharmacol; 2019 Sep; 96(3):355-363. PubMed ID: 31263019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated computational tools for identification of CCR5 antagonists as potential HIV-1 entry inhibitors: homology modeling, virtual screening, molecular dynamics simulations and 3D QSAR analysis.
    Moonsamy S; Dash RC; Soliman ME
    Molecules; 2014 Apr; 19(4):5243-65. PubMed ID: 24762964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking of competitive inhibitors to the P2X7 receptor family reveals key differences responsible for changes in response between rat and human.
    Caseley EA; Muench SP; Baldwin SA; Simmons K; Fishwick CW; Jiang LH
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3164-7. PubMed ID: 26099538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.